Literature DB >> 17402695

[Predictive factors of dengue shock syndrome at the children Hospital No. 1, Ho-chi-Minh City, Vietnam].

T B Pham1, T H Nguyen, T Q H Vu, T L Nguyen, D Malvy.   

Abstract

The dengue shock syndrome (DSS) is primarily a complication of dengue haemorrhagic fever (DHF) among children in South East Asia. A case-control study was carried out at the children hospital no 1 (Ho-Chi-Minh City, Vietnam) in May-July 2005, to identify the predictive factors of the DSS among 1-15 year patients with DHE Forty consecutive admitted cases and forty controls were studied. The associated features of DSS were the 7-12 year age group and the re-infection by the dengue virus. The vaccination against the Japanese encephalitis B was not associated statistically significantly with the shock syndrome. The clinical predictors of DSS gathered an abdominal tenderness, an hepatomegaly, a lethargy, a cold extremity presentation. DSS associated laboratory features were a value of hematocrit a 50 % and a platelet cell count < or = 75,000/mm3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17402695

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  8 in total

1.  Elevated levels of cell-free circulating DNA in patients with acute dengue virus infection.

Authors:  Tran Thi Ngoc Ha; Nguyen Tien Huy; Lyre Anni Murao; Nguyen Thi Phuong Lan; Tran Thi Thuy; Ha Manh Tuan; Cao Thi Phi Nga; Vo Van Tuong; Tran Van Dat; Mihoko Kikuchi; Michio Yasunami; Kouichi Morita; Vu Thi Que Huong; Kenji Hirayama
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

Review 2.  Association between nutritional status and dengue infection: a systematic review and meta-analysis.

Authors:  Nguyen Thi Huyen Trang; Nguyen Phuoc Long; Tran Thi Minh Hue; Le Phi Hung; Tran Dinh Trung; Doan Ngoc Dinh; Nguyen Thien Luan; Nguyen Tien Huy; Kenji Hirayama
Journal:  BMC Infect Dis       Date:  2016-04-20       Impact factor: 3.090

3.  Differences in clinical features and dengue severity between local and migrant Chinese with dengue infection in Singapore.

Authors:  Chuanhui Xu; Junxiong Pang; Jung Pu Hsu; Yee Sin Leo; David Chien Boon Lye
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

4.  Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome.

Authors:  Thi Phuong Lan Nguyen; Mihoko Kikuchi; Thi Que Huong Vu; Quang Ha Do; Thi Thuy Tran; Dinh Tham Vo; Manh Tuan Ha; Van Tuong Vo; Thi Phi Nga Cao; Van Dat Tran; Toshifumi Oyama; Kouichi Morita; Michio Yasunami; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2008-10-01

Review 5.  Factors associated with dengue shock syndrome: a systematic review and meta-analysis.

Authors:  Nguyen Tien Huy; Tran Van Giang; Dinh Ha Duy Thuy; Mihoko Kikuchi; Tran Tinh Hien; Javier Zamora; Kenji Hirayama
Journal:  PLoS Negl Trop Dis       Date:  2013-09-26

6.  Risk factors associated with death in Brazilian children with severe dengue: a case-control study.

Authors:  Maria dos Remédios Freitas Carvalho Branco; Expedito José de Albuquerque Luna; Leônidas Lopes Braga Júnior; Ricardo Villar Barbosa de Oliveira; Lívia Teresa Moreira Rios; Maria do Socorro da Silva; Maria Nilza Lima Medeiros; Gilnara Fontinelle Silva; Fernanda Campos Amaral Figueiredo Nina; Taliane Jardim Lima; Jayron Alves Brito; Avessandra Costa Cardoso de Oliveira; Claudio Sergio Pannuti
Journal:  Clinics (Sao Paulo)       Date:  2014-01       Impact factor: 2.365

7.  Risk factors for shock in children with dengue fever.

Authors:  Sriram Pothapregada; Banupriya Kamalakannan; Mahalakshmy Thulasingham
Journal:  Indian J Crit Care Med       Date:  2015-11

8.  Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children.

Authors:  Win Lai May; Myat Phone Kyaw; Stuart D Blacksell; Sasithon Pukrittayakamee; Kesinee Chotivanich; Borimas Hanboonkunupakarn; Khin Nyo Thein; Chae Seung Lim; Janjira Thaipadungpanit; Thomas Althaus; Podjanee Jittamala
Journal:  PLoS One       Date:  2019-01-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.